US › Healthcare

Pluri Inc. (PLUR)

US · Healthcare · Biotechnology

$0.93-1.06%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$335,000

Revenue YoY

-15.8%

Net profit

$-5.9M

EPS

$-0.54

Net margin

-1,755.2%

Key statistics

Market cap

$11.7M

Forward P/E

3.6

P/B

306.56

Book value

$-2.13

EPS (TTM)

$-2.44

52-week high

$4.87

52-week low

$0.85

50-day MA

$1.29

200-day MA

$2.48

Beta

0.69

Analyst view

with an average price target of $12.00.

Shareholding

Insiders

42.52%

Institutions

20.68%

Largest institutional holders

Fund	Stake
Renaissance Technologies Corp	0.15%
Morgan Stanley - Brokerage Accounts	0.02%
EverSource Wealth Advisors, LLC	0.02%
UBS Group AG	0.02%
SIMA Wealth Partners, LLC	0.00%
Citigroup Inc	0.00%
Wells Fargo & Co	0.00%
Royal Bank of Canada	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Pluri Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.